🌟 Allergy & Asthma Network unites and advocates on behalf of 60 million Americans with #asthma 😷, #allergies 🤧 and related conditions. Learn more ⬇️ AllergyAsthmaNetwork.org https://bsky.app/profile/allergyasthmahq.bsky.socialhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mvlkvk3rtc2dNew #MYTHBUSTING episode 🎧 Patients often think starting a biologic is irreversible. Is that true? Dr. Giselle Mosnaim, Kortney & Dr. Gupta bust the biggest biologics myths for asthma, COPD & nasal polyps and how to address them in practice.15 Sep 2026 21:27 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mvlkvk3rtc2dhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mvazhwbgd22jAstraZeneca has announced full results from the Phase III OBERON and TITANIA trials evaluating tozorakimab, an investigational biologic, in adults living with COPD.  #COPD #RespiratoryHealth #ClinicalTrials #LungHealth #PatientAdvocacy https://www.astrazeneca-us.com/content/az-us/media/press-releases/2026/Tozorakimab-demonstrated-statistically-significant-and-highly-clinically-meaningful-reduction-in-COPD-exacerbations-in-OBERON-and-TITANIA-Phase-III-trials.html11 Sep 2026 16:48 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mvazhwbgd22jhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mu3ercre7c25Being on medication doesn't mean the risk conversation is over when it comes to September Asthma Peak, especially for adults. Every September, a predictable spike in asthma flares hits, and adults are just as vulnerable as kids, even when their asthma feels stable.27 Aug 2026 17:29 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mu3ercre7c25https://bsky.app/profile/allergyasthmahq.bsky.social/post/3mtcm5ixuyc2eARS Pharma has announced that every neffy prescription now includes a carry case at no additional cost to patients which is designed to support making neffy easier to carry so epinephrine is readily accessible at all times.17 Aug 2026 21:05 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mtcm5ixuyc2ehttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mtcirwksmk2mOur thoughts are with the family and loved ones of Christy Knowings, beloved for her role on Nickelodeon's "All That," who passed away this week following an asthma attack. Her passing is a heartbreaking reminder that asthma is serious and can be unpredictable. https://ControlYourAsthma.org17 Aug 2026 20:05 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mtcirwksmk2mhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3msxub3yzdc24Aquestive Therapeutics has announced positive results from its recent studies for Anaphylm™ (dibutepinephrine), an investigational sublingual film designed to deliver epinephrine without an injection. https://investors.aquestive.com/news-releases/news-release-details/aquestive-therapeutics-announces-positive-topline-human-factors13 Aug 2026 14:31 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3msxub3yzdc24https://bsky.app/profile/allergyasthmahq.bsky.social/post/3msveubzvvk2aDo you work with patients who have asthma and chronic sinus problems? The two conditions may be closely related. The nose, sinuses and lungs are part of a “united airway” and that means inflammation in the upper airways can potentially trigger asthma in the lower airways.12 Aug 2026 14:50 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3msveubzvvk2ahttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mrujmywft22h🎧 The food choices you make in your baby's first year could shape their immune system for life. New research suggests that what (and how) you introduce solids may influence your baby's gut microbiome and their risk of developing food allergies.30 Jul 2026 13:17 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mrujmywft22hhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mrppza2t4c2sAdvances in medicine are creating NEW options for people living with chronic hives. Advanced treatments include: • Biologic therapies • A new targeted oral medicine that stops histamine release, called a BTK inhibitor. These options may help achieve better symptom control. More: ChronicHives.info28 Jul 2026 15:28 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mrppza2t4c2shttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mrcsuecdj22p⚠️ RECALL ALERT: Unique Pharmaceutical Laboratories is voluntarily recalling 4 lots of Cetirizine HCl Tablets USP 5mg (Zyrtec generic, NDC 16571-401-10) due to possible cross-contamination with ranitidine. This is a risk for anyone allergic to ranitidine. Check your bottles. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/unique-pharmaceutical-laboratories-div-j-b-chemicals-pharmaceuticals-ltd-issues-voluntary-nationwide23 Jul 2026 12:15 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mrcsuecdj22phttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mr3qc6ofp22xChronic hives are more common than most people realize, and more misunderstood. One of the biggest myths we hear from patients: hives must mean an allergy. But when hives last more than 6 weeks, the cause is usually not a specific allergen.20 Jul 2026 16:40 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mr3qc6ofp22xhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mqoxcmflgc2aLos corticosteroides orales (COS) pueden ayudar en situaciones de emergencia, pero su uso excesivo puede provocar efectos secundarios graves. La Dra. Juanita Mora explica los efectos secundarios graves a largo plazo derivados del uso excesivo de COS,15 Jul 2026 14:41 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mqoxcmflgc2ahttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mqmllk6ft22ySymptom burden in #CRSwNP extends beyond congestion. Quality of life indicators such as sleep disruption, fatigue, impaired smell/taste, and reduced daily functioning are common.14 Jul 2026 16:06 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mqmllk6ft22yhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mqk5dolk5s2pLos bebés no pueden decirnos cuando les pasa algo. Esto hace que reconocer la anafilaxia sea crítico. 🚨Los signos de anafilaxia en bebés pueden incluir: 👶 Urticaria, sarpullido o hinchazón (especialmente en labios o cara) 😮‍💨 Tos, silbidos, o dificultad para respirar 🤢 Vómitos o diarrea13 Jul 2026 16:46 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mqk5dolk5s2phttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mqa7ujgnic2aFor most patients with chronic spontaneous urticaria, broad allergy and blood testing rarely identifies a cause, yet it's still routinely ordered. In this #podcast episode, Dr. Michael Blaiss joins Kortney Kwong Hing and Dr. Gupta, to break down the new draft chronic hives guidelines:09 Jul 2026 18:04 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mqa7ujgnic2ahttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mpjlhrukn42oWe're presenting two On Demand/Digital sessions at the 2026 National Association of County and City Health Officials 360 Conference, taking place July 14-17 in Louisville, KY and virtually. Last chance to attend virtually- https://www.naccho360.com/registration/digital-registration #NA360 30 Jun 2026 18:00 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mpjlhrukn42ohttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mpgkdxrtoc22Research into a potential new oral treatment for atopic dermatitis (AD) is moving forward. Kymera Therapeutics has completed enrollment for its BROADEN2 Phase 2b clinical trial of KT-621, an investigational once-daily oral medication (pill) for AD. https://investors.kymeratx.com/news-releases/news-release-details/kymera-therapeutics-completes-enrollment-phase-2b-broaden2-trial29 Jun 2026 13:02 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mpgkdxrtoc22https://bsky.app/profile/allergyasthmahq.bsky.social/post/3modtji57zc2i⚽ World Cup fever is on! Don't let asthma sideline you. Take your controller meds daily, carry your quick-relief inhaler, know your triggers & follow your action plan. Score a goal for your health 🥅 Visit ControlYourAsthma.org #ControlYourAsthma #WorldCup202615 Jun 2026 17:43 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3modtji57zc2ihttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3modokuevyx2jDirector of Community Support Programs Leandra Tonweber PA-C, to present “Decreased Systemic Steroid Use and Improved Asthma Control After Virtual Asthma Self‑Management Education" at the Association of Pulmonary Advanced Practice Providers National Conference. https://www.pulmapplive.com/ 15 Jun 2026 16:15 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3modokuevyx2jhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mo3v7jl6ds23At Allergy & Asthma Network, we hear it all the time from providers: "My patients don't realize their asthma is uncontrolled." And they're right. If your patients are experiencing any of the following, it's time to revisit their treatment plan:12 Jun 2026 13:52 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mo3v7jl6ds23https://bsky.app/profile/allergyasthmahq.bsky.social/post/3mnx6hrfzns2dThe U.S. FDA has approved a new maintenance dosing schedule for @elilillyandcompany.bsky.social Ebgylss (lebrikizumab-lbkz), allowing patients ages 12 and older with moderate-to-severe atopic dermatitis to receive treatment once every eight weeks of a single injection (250 mg/2 mL). https://lilly.mediaroom.com/2026-06-09-FDA-approves-Lillys-EBGLYSS-R-lebrikizumab-lbkz-for-one-maintenance-dose-every-eight-weeks-in-patients-with-moderate-to-severe-atopic-dermatitis10 Jun 2026 16:55 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mnx6hrfzns2dhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mnshwb7dzv2pCMS' new Medicaid work requirements risk cutting off care for people with asthma and other chronic conditions. We oppose this rule and urge states to reduce barriers to coverage. https://allergyasthmanetwork.org/press-page/statement-on-work-requirements-medicaid/ #CMS #medicaid #patientsfirst08 Jun 2026 20:01 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mnshwb7dzv2phttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mnl57wbd5b2lWe’re proud to partner with Mediaplanet on the Lung Health campaign, highlighting tools helping to improve respiratory health and support long-term wellbeing. https://www.futureofpersonalhealth.com/lung-health/living-with-asthma-dont-settle-for-not-breathing-well/ #LungHealth #BetterBreathing05 Jun 2026 22:00 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mnl57wbd5b2lhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mncgicvmzc2qDo your patients ever ask you questions about dating with food allergies? Such as... • How do you kiss someone when you have a food allergy? • What about when things get even more intimate? • And what does a safe date night even look like?02 Jun 2026 10:52 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mncgicvmzc2qhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mn37le2ht32vHabla español? Language should never be a barrier to healthcare. Allergy & Asthma Network provides asthma and allergy education resources in Spanish to help more families access trusted information. 🔗 redalergiayasma.org 🔗 ControlarTuAsma.org30 May 2026 14:00 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mn37le2ht32vhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mmylx64kns2jApogee Therapeutics has announced positive 16-week results from APEX Part B, a Phase 2 study of zumilokibart in adults with moderate-to-severe atopic dermatitis. The study met all of its goals, with 65.9% of participants on the mid-dose seeing at least a 75% improvement in their condition https://investors.apogeetherapeutics.com/news-releases/news-release-details/apogee-therapeutics-host-conference-call-report-part-b-16-week29 May 2026 13:03 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mmylx64kns2jhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mmw56qvi7s2nToo many people believe their asthma is “fine” even when symptoms interrupt sleep, limit activity, or require frequent quick‑relief inhaler use. These are signs of uncontrolled asthma. Uncontrolled asthma leads to preventable ER visits, missed school and workdays, and avoidable complications.28 May 2026 13:34 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mmw56qvi7s2nhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mmuiytfrgk2hNasal congestion that won’t go away? Loss of smell? It could be chronic rhinosinusitis with nasal polyps which is often driven by Type 2 inflammation. 📝 Take the symptom quiz + explore treatment options: AllergyAsthmaNetwork.org/CRSwNP #CRSwNP #NasalPolyps #Type2Inflammation 27 May 2026 22:00 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mmuiytfrgk2hhttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mmtx66zysc2eSevere allergies don't have to mean missing out on life and Gregg Clark knows that first hand. With the right preparation and knowledge, you can still enjoy the outdoors, share meals, and be present with the people you love. Visit allergyasthmanetwork.org to learn more.27 May 2026 16:41 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mmtx66zysc2ehttps://bsky.app/profile/allergyasthmahq.bsky.social/post/3mmryk7prt222Today is #TruthTuesday… Myth: “You can outgrow asthma.” Truth: While symptoms may improve, asthma never truly goes away. Stay on top of your care plan! ✅ More myths busted: https://allergyasthmanetwork.org/what-is-asthma/' #AsthmaAwarenessMonth #Asthma26 May 2026 22:00 +0000at://did:plc:apobz4ydqbdnhfbgr4lprhtq/app.bsky.feed.post/3mmryk7prt222